Sify.com » Topics » Generics
Generics News
Lupin among top five generic drug companies in US
Drug maker Lupin has become one of the top five generic drug companies operating in the US market in terms of number of prescriptions. This is a first among Indian generic companies selling drugs in the US, the largest market in the world. A generic drug is one produced and distributed without patent protection. Lupin is now behind Teva Pharma of Israel, Mylan Labs, Novartis and Watson Pharma. It
Drug maker Lupin has become one of the top five generic drug companies operating in the US market in terms of number of prescriptions. This is a first among Indian generic companies selling drugs in the US, the largest market in the world. A generic drug is one produced and distributed without patent protection. Lupin is now behind Teva Pharma of Israel, Mylan Labs, Novartis and Watson Pharma. It
Abbott buys unit of Piramal Healthcare for $3.7B
Abbott Laboratories has agreed to buy the domestic healthcare business of India's Piramal Healthcare Ltd., a leading branded generics company, for $3.72 billion, the companies said Friday.
Abbott Laboratories has agreed to buy the domestic healthcare business of India's Piramal Healthcare Ltd., a leading branded generics company, for $3.72 billion, the companies said Friday.
'This country has great opportunity for generics business'
Acquiring Piramal Healthcare’s domestic business will make Abbott the largest drug company in India in market share and the largest multinational one. In a telephonic interview with P B
Glenmark enters into licensing pact with Taro's US arm
Glenmark Generics Inc, a wholly-owned subsidiary of Glenmark Generics Ltd, has entered into an exclusive licensing agreement with the US arm of Israel-based Taro Pharmaceuticals to sell a branded
Patent office rejects Roche claim on eye drug
Swiss drug multinational Roche AG suffered yet another setback in its ongoing patent fights in India after the Chennai patent office rejected its claim over Valcyte (valganciclovir).
Swiss drug multinational Roche AG suffered yet another setback in its ongoing patent fights in India after the Chennai patent office rejected its claim over Valcyte (valganciclovir).
US healthcare Bill: Gains for Indian pharma
The healthcare reform Bill proposed by US President Barack Obama is now a law as the Patient Protection and Affordable Care Act. With the US market accounting for about half the global pharma sales,
The healthcare reform Bill proposed by US President Barack Obama is now a law as the Patient Protection and Affordable Care Act. With the US market accounting for about half the global pharma sales,
© Copyright Sify Technologies Ltd, 1998-2011. All rights reserved. India News Portal, Sify.com hosted at SifyHosting India's first Level 3 Internet Data Centre.
Site optimized for Internet Explorer 5.5 and above.
See Disclaimer |Privacy Policy &Parental Guidance on pornography |careers@sify |About Us |Feedback |Advertise
Site optimized for Internet Explorer 5.5 and above.
See Disclaimer |Privacy Policy &Parental Guidance on pornography |careers@sify |About Us |Feedback |Advertise